The PDRN explosion of 2026
Polydeoxyribonucleotide — PDRN — was a clinical injectable in Korean dermatology for over a decade before going mass-market. By 2026, it appears on every shelf of Olive Young in serums, creams, sheet masks, and "ampoules." The injectable version (Rejuran) still dominates clinic menus. Both claim the same mechanism: salmon DNA fragments that bind adenosine A2A receptors, triggering cell proliferation and collagen synthesis.
Same ingredient. Two completely different delivery methods. The question patients keep asking: do the topical bottles actually work, or are they riding the clinical injectable's reputation?
What PDRN does at the cell level
PDRN molecules are DNA fragments 50–1500 base pairs long. They bind A2A receptors on fibroblasts and keratinocytes, stimulating:
- Cell proliferation (faster turnover)
- Collagen and elastin synthesis
- Vascular endothelial growth factor (VEGF) release — better microcirculation
- Anti-inflammatory cytokine modulation
- Hyaluronic acid production by fibroblasts
The mechanism is well-documented in dermatological literature for the injectable form. The question is whether topical application achieves enough penetration to trigger the same response.
Injectable PDRN (Rejuran)
Delivers PDRN directly into the dermis at clinically-validated concentrations through 1.5–2.5 mm needle depth. Typical protocol: 3 sessions, 4 weeks apart.
- Concentration delivered to dermis: high (2% PDRN solution into target tissue)
- Cost in Gangnam: ₩250,000–500,000 per session ($190–380)
- Total course: ₩750,000–1,500,000 ($570–1,140)
- Results timeline: collagen improvements at 6–8 weeks, peak at 12 weeks
- Downtime: 1–3 days of small punctate bruising
- Evidence: Multiple peer-reviewed studies showing measurable improvement in skin elasticity, texture, and pore size
Topical PDRN
Applied via serum/cream/sheet mask. Penetration depth limited by the stratum corneum (the dead-cell skin barrier is roughly 10–20 micrometers thick — most molecules over 500 daltons can't cross it without enhancers).
- PDRN molecular weight: 50,000–1,500,000 daltons (significantly larger than typical skincare actives)
- Concentration at fibroblast level: minimal without microneedling or sonophoresis
- Cost: ₩15,000–80,000 per bottle ($11–60)
- Results timeline: vague, often confounded with other formulation ingredients
- Evidence: very limited clinical data on topical-only PDRN delivery
Where topical PDRN does help
Honest answer: topical PDRN serums do help skin, but probably not via the headline mechanism. The benefits patients report are usually attributable to:
- Hydrating peptides and humectants in the same formulation
- Niacinamide commonly included for brightening
- Centella and panthenol for calming
- Hyaluronic acid for plumping
- Small amounts of low-molecular-weight PDRN fragments that may penetrate
You're paying for a competently formulated K-beauty serum with PDRN branding. The serum itself works. The PDRN-specific benefit is unclear.
The hybrid approach Korean clinics recommend
Most Gangnam dermatologists in 2026 recommend a structured protocol if patients want PDRN-driven results: do the injectable course first (3 sessions), then use topical PDRN serum + occasional sheet masks as maintenance during the 6-month gap before re-injection. This maximizes the injectable's effect and gives the topical a meaningful supporting role.
Honest framing
If you have a budget for one PDRN intervention, do the injectable. If you can't afford the injectable, a topical PDRN serum is a reasonable purchase but should be evaluated as a general moisturizing serum rather than a regenerative treatment — buy the one with the supporting ingredients (niacinamide, peptides) you want regardless of the PDRN claim. The 2026 marketing makes the topical sound equivalent to the injectable. It is not.